Batti Jalao

The average health insurer in India spends roughly Rs.3,200 to acquire a customer who pays Rs.8,000 a year in premium. That's a 40% acquisition cost ratio — on a product with thin margins, high claim payouts, and a customer who might lapse after year one if nobody reminds them why they bought the policy in the first place. And most insurance marketing teams are still running the same playbook: fear-based TV ads, generic Google campaigns targeting "best health insurance," and

Let me tell you about two senior care homes in the same city. Both have clean rooms, both have round-the-clock nursing staff, both charge roughly the same monthly fee and both opened within a year of each other. One has 92% occupancy while the other has been stuck at 55% for 18 months. The difference? The first one markets to the daughter and the second one markets to the senior. That single strategic decision, understanding who the real decision-maker is, separates nursing

Indian pharma is standing at a crossroads nobody saw coming. The rules of engagement have changed, the tools have changed, and the doctors themselves have changed how they consume information. Most pharma brands haven't noticed yet. The medical rep still matters. But the MR's window in the chamber has shrunk to seconds, not minutes, post-pandemic. Meanwhile, 95% of Indian doctors use WhatsApp every single day. HCPs are consuming bite-sized clinical content between OPD cases,